PatientsVille.com Logo

PatientsVille

Sifrol Side Effects

Common Sifrol Side Effects


The most commonly reported Sifrol side effects (click to view or check a box to report):

Suicide Attempt (23)
Hallucination (18)
Somnolence (17)
Overdose (15)
Oedema Peripheral (15)
Confusional State (14)
Nausea (11)
Death (11)
Cardiac Failure (10)
Anxiety (10)
Gambling (10)
Fatigue (10)
Muscle Spasms (10)
Condition Aggravated (9)
Angina Pectoris (9)
Dizziness (9)
Hypotension (9)
Tremor (9)
Vomiting (9)
Pyrexia (8)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Sifrol Side Effects Reported to FDA

The following Sifrol reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Sifrol on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Coma, Toxicity To Various Agents
This is a report of a 61-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: parkinson^s disease, who was treated with Sifrol (dosage: 2.6 Mg, start time: NS), combined with:
  • Modopar (15625 Mg)
  • Clozapine (750 Mg)
  • Stalevo (12500 Mg)
  • Celectol (3000 Mg)
  • Idarac 200 Mg (8000 Mg)
  • Stalevo 150mg/37.5mg/200 Mg (14100 Mg)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Coma
  • Toxicity To Various Agents
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sifrol treatment in female patients, resulting in coma side effect. The patient was hospitalized.

Coma
This report suggests a potential Sifrol Coma side effect(s) that can have serious consequences. A 70-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: parkinson^s disease,sedation and used Sifrol (dosage: Dose Per Application:0.26 In The Morning And 0.52 In The Morning And In The Evening.) starting Nov 24, 2013. Soon after starting Sifrol the patient began experiencing various side effects, including:
  • Coma
Drugs used concurrently:
  • Tercian (100 Mg)
  • Seresta 100mg
Although Sifrol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as coma, may still occur.

Cardiac Failure
This Cardiac Failure problem was reported by a health professional from FR. A 87-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: restless legs syndrome. On 201310 this consumer started treatment with Sifrol (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Sifrol, the patient experienced the following unwanted symptoms/side effects:
  • Cardiac Failure
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as cardiac failure, may become evident only after a product is in use by the general population.

Narcolepsy, Hypersomnia, Fall
This is a report of a 83-year-old male patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: parkinson^s disease and was treated with Sifrol (dosage: 0.375 Mg) starting 2012. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Narcolepsy
  • Hypersomnia
  • Fall
The patient was hospitalized. This opens a possibility that Sifrol treatment could cause the above reactions, including narcolepsy, and some male subjects may be more susceptible.


Delirium, Anxiety, Hallucination, Aggression, Cognitive Disorder
A 83-year-old female patient (weight: NA) from DK with the following symptoms/conditions: restless legs syndrome started Sifrol treatment (dosage: Daliy Dose:1 And Half Tablet) on Oct 24, 2012. Soon after starting Sifrol treatment, the subject experienced various side effects, including:
  • Delirium
  • Anxiety
  • Hallucination
  • Aggression
  • Cognitive Disorder
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Sifrol.

Kyphosis, Dystonia, Back Pain
A 65-year-old male patient from FR (weight: NA) experienced symptoms, such as: NA and was treated with Sifrol(dosage: 0.52 Mg). The treatment was initiated on 201306. After that a consumer reported the following side effect(s):
  • Kyphosis
  • Dystonia
  • Back Pain
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Sifrol efficacy: NA.The patient was hospitalized.

Acute Psychosis, Alcohol Interaction
In this report, Sifrol was administered for the following condition: restless legs syndrome.A 52-year-old female consumer from GB (weight: NA) started Sifrol treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Acute Psychosis
  • Alcohol Interaction
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Sifrol treatment could be related to the listed above side effect(s).

Impulse-control Disorder, Pathological Gambling, Dependence, Eating Disorder
This is a report of the following Sifrol side effect(s):
  • Impulse-control Disorder
  • Pathological Gambling
  • Dependence
  • Eating Disorder
A 58-year-old male patient from FR (weight: NA) presented with the following condition: parkinson^s disease and received a treatment with Sifrol (dosage: 2.1 Mg) starting: 201109.The following concurrently used drugs could have generated interactions:
  • Stalevo (650 Mg)
  • Azilect (1 Mg)
  • Sinemet (200 Mg)
This report suggests that a Sifrol treatment could be associated with the listed above side effect(s).

Hypothermia, Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia, Altered State Of Consciousness, Sedation, Depressed Level Of Consciousness
This Sifrol report was submitted by a 84-year-old female consumer from CH (weight: NA). The patient was diagnosed with: restless legs syndrome,hypertension and Sifrol was administered (dosage: 0.12 Mg) starting: NS. The consumer developed a set of symptoms:
  • Hypothermia
  • Inappropriate Antidiuretic Hormone Secretion
  • Hyponatraemia
  • Altered State Of Consciousness
  • Sedation
  • Depressed Level Of Consciousness
Other drugs used simultaneously:
  • Oedemex/furosemide (40 Mg)
  • Ramipril Actavis/ramipril (2.5 Mg)
  • Beloc/metorpolol Tartrate/metoprolol Succinate
  • Glimeryl Mepha/glimepiride (4 Mg)
  • Metfin/metformin Hydrochloride (1000 Mg)
  • Acidum Folicum Streuli/fokic Acid (5 Mg)
  • Magnesium (Dose Per Application 5mmol)
  • Stilnox/zolpidem Tartrate (10 Mg)
The patient was hospitalized.Those unexpected symptoms could be linked to a Sifrol treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Talipes, Restless Legs Syndrome, Dyskinesia, Arthralgia, Muscle Spasms, Hypochromic Anaemia, Iron Deficiency Anaemia
This is a report of a possible correlation between Sifrol use and the following symptoms/side effect(s):
  • Talipes
  • Restless Legs Syndrome
  • Dyskinesia
  • Arthralgia
  • Muscle Spasms
  • Hypochromic Anaemia
  • Iron Deficiency Anaemia
which could contribute to an assessment of Sifrol risk profile.A 32-year-old female consumer from COUNTRY NOT SPECIFIED (weight: NA) was suffering from restless legs syndrome and was treated with Sifrol (dosage: 0.5 Mg) starting 2009.Other concurrent medications:
  • Gabapentin Encarbil (300 Mg)
The patient was hospitalized.

Hepatitis, Haematoma
A 90-year-old female patient from FR (weight: NA) presented with the following symptoms: NA and after a treatment with Sifrol (dosage: NA) experienced the following side effect(s):
  • Hepatitis
  • Haematoma
The treatment was started on NS. Sifrol was used in combination with the following drugs:
  • Previscan
  • Doliprane
  • Lamaline
  • Xanax
  • Oxycontin
  • Lasilix
  • Cardensiel
  • Inexium
The patient was hospitalized.This report could alert potential Sifrol consumers.

Vascular Graft, Dry Mouth, Dysphagia, Off Label Use
In this report, a 50-year-old female patient from FR (weight: NA) was affected by a possible Sifrol side effect.The patient was diagnosed with restless legs syndrome,asthma. After a treatment with Sifrol (dosage: 0.18 Mg X 2 Daily, start date: 201212), the patient experienced the following side effect(s):
  • Vascular Graft
  • Dry Mouth
  • Dysphagia
  • Off Label Use
The following simultaneously used drugs could have led to this reaction:
  • Spiriva
  • Corticoids
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Sifrol treatment.

Fatigue, Malaise, Hiccups, Hallucination, Confusional State, Delusion
This is a report of a 65-year-old male patient from SE (weight: NA), who used Sifrol (dosage: 0.54 Mg) for a treatment of parkinsonism. After starting a treatment on Jul 22, 2013, the patient experienced the following side effect(s):
  • Fatigue
  • Malaise
  • Hiccups
  • Hallucination
  • Confusional State
  • Delusion
The following drugs could possibly have interacted with the Sifrol treatment NA.Taken together, these observations suggest that a Sifrol treatment could be related to side effect(s), such as Fatigue, Malaise, Hiccups, Hallucination, Confusional State, Delusion.

Eyelid Oedema, Conjunctival Hyperaemia, Restless Legs Syndrome
This eyelid oedema side effect was reported by a physician from BE. A 65-year-old male patient (weight:NA) experienced the following symptoms/conditions: restless legs syndrome. The patient was prescribed Sifrol (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Sifrol the consumer reported the following symptoms:
  • Eyelid Oedema
  • Conjunctival Hyperaemia
  • Restless Legs Syndrome
These side effects may potentially be related to Sifrol.

Impulse-control Disorder, Dependence, Eating Disorder, Hypersexuality
This is a Sifrol side effect report of a 62-year-old female patient (weight:NA) from FR, suffering from the following symptoms/conditions: parkinson^s disease, who was treated with Sifrol (dosage:0.54 Mg, start time: 201302), combined with: NA., and developed a serious reaction and a impulse-control disorder side effect. The patient presented with:
  • Impulse-control Disorder
  • Dependence
  • Eating Disorder
  • Hypersexuality
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Sifrol treatment in female patients suffering from parkinson^s disease, resulting in impulse-control disorder.

Compression Fracture, Overdose
This report suggests a potential Sifrol compression fracture side effect(s) that can have serious consequences. A 59-year-old male patient from JP (weight:NA) was diagnosed with the following health condition(s): parkinson^s disease and used Sifrol (dosage: 3 Mg) starting Sep 09, 2013. Soon after starting Sifrol the patient began experiencing various side effects, including:
  • Compression Fracture
  • Overdose
Drugs used concurrently:NA. The patient was hospitalized. Although Sifrol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as compression fracture, may still occur.

Pain In Extremity, Muscle Rigidity, Erythema, Local Swelling, Gait Disturbance
This pain in extremity problem was reported by a consumer or non-health professional from FR. A 53-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): parkinson^s disease.On 201007 a consumer started treatment with Sifrol (dosage: 0.52 Mg). The following drugs/medications were being taken at the same time:
  • Azilect
  • Calcium
When commencing Sifrol, the patient experienced the following unwanted symptoms /side effects:
  • Pain In Extremity
  • Muscle Rigidity
  • Erythema
  • Local Swelling
  • Gait Disturbance
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as pain in extremity, may become evident only after a product is in use by the general population.

Completed Suicide
This is a Sifrol side effect report of a 62-year-old male patient (weight: NA) from CH. The patient developed the following symptoms/conditions: NA and was treated with Sifrol (dosage: NA) starting Jun 21, 2013. Concurrently used drugs:
  • Abilify
  • Abilify
  • Abilify
  • Abilify
  • Abilify
  • Remeron Soltab
  • Remeron Soltab
  • Seresta
Soon after that, the consumer experienced the following of symptoms:
  • Completed Suicide
This opens a possibility that Sifrol could cause completed suicide and that some male patients may be more susceptible.

Extrapyramidal Disorder, Renal Failure Acute, Muscle Spasms, Blepharospasm, Trismus, Bradycardia, Hypotension
A 68-year-old male patient (weight: NA) from SE with the following symptoms: fatigue,nocturia started Sifrol treatment (dosage: 1.05 Mg) on NS. Soon after starting Sifrol treatment, the consumer experienced several side effects, including:
  • Extrapyramidal Disorder
  • Renal Failure Acute
  • Muscle Spasms
  • Blepharospasm
  • Trismus
  • Bradycardia
  • Hypotension
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Sifrol side effects, such as extrapyramidal disorder.

Somnolence
This somnolence side effect was reported by a physician from COUNTRY NOT SPECIFIED. A 43-year-old female patient (weight:NA) experienced the following symptoms/conditions: restless legs syndrome.The patient was prescribed Sifrol (dosage: 5 Anz), which was started on Jul 29, 2013. Concurrently used drugs:
  • Zopiclon 7.5 (5 Anz)
  • Tavor (4 Anz)
.When starting to take Sifrol the consumer reported symptoms, such as:
  • Somnolence
These side effects may potentially be related to Sifrol.

Eating Disorder Symptom, Hypersexuality, Compulsive Shopping
This is a report of a 54-year-old male patient (weight: NA) from FR, suffering from the following symptoms/conditions: parkinson^s disease, who was treated with Sifrol (dosage: NA, start time: 200609), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Eating Disorder Symptom
  • Hypersexuality
  • Compulsive Shopping
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sifrol treatment in male patients, resulting in eating disorder symptom side effect.

Diplopia
This report suggests a potential Sifrol Diplopia side effect(s) that can have serious consequences. A 63-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: restless legs syndrome and used Sifrol (dosage: 0.18 Mg) starting 201204. Soon after starting Sifrol the patient began experiencing various side effects, including:
  • Diplopia
Drugs used concurrently: NA. Although Sifrol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as diplopia, may still occur.

Lumbar Vertebral Fracture
This Lumbar Vertebral Fracture problem was reported by a pharmacist from JP. A 75-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Sifrol (dosage: 0.75 Mg). The following drugs were being taken at the same time:
  • Menesit
  • Amlodipine
  • Gasmotin
When commencing Sifrol, the patient experienced the following unwanted symptoms/side effects:
  • Lumbar Vertebral Fracture
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as lumbar vertebral fracture, may become evident only after a product is in use by the general population.

Camptocormia, Back Pain
This is a report of a 61-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: parkinson^s disease and was treated with Sifrol (dosage: 1.5 Mg) starting May 16, 2006. Concurrently used drugs:
  • Symmetrel (100 Mg)
  • Opalmon (15 Mcg)
  • Neurotropin (12 U)
  • Artane (6 Mg)
  • Almarl (20 Mg)
  • Lipitor (10 Mg)
  • Fp (2.5 Mg)
  • Celecox (200 Mg)
Soon after that, the consumer experienced the following side effects:
  • Camptocormia
  • Back Pain
The patient was hospitalized. This opens a possibility that Sifrol treatment could cause the above reactions, including camptocormia, and some female subjects may be more susceptible.

Camptocormia, Back Pain
A 73-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED with the following symptoms/conditions: parkinson^s disease started Sifrol treatment (dosage: 1 Mg) on NS. Soon after starting Sifrol treatment, the subject experienced various side effects, including:
  • Camptocormia
  • Back Pain
Concurrently used drugs:
  • Levodopa/benserazide
  • Voglibose Od (0.6 Mg)
  • Mevarich (10 Mg)
  • Diovan (8 Mg)
  • Lendormin (0.25 Mg)
  • Ec-doparl (1.5 Mg)
  • Rivotril (0.5 Mg)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Sifrol.

1 of 12 



Top 10 Sifrol Side Effects for Women

Women Side EffectsReports
Suicide Attempt 16
Somnolence 12
Oedema Peripheral 11
Anxiety 9
Confusional State 9
Gambling 9
Nausea 9
Death 8
Overdose 8
Circulatory Collapse 7

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Sifrol Side Effects

    Did You Have a Sifrol Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Sifrol for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective